These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 25584808)

  • 41. Mutations causing Gaucher disease.
    Horowitz M; Zimran A
    Hum Mutat; 1994; 3(1):1-11. PubMed ID: 8118460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of LIMP-2 in the intracellular trafficking of β-glucosidase in different human cellular models.
    Malini E; Zampieri S; Deganuto M; Romanello M; Sechi A; Bembi B; Dardis A
    FASEB J; 2015 Sep; 29(9):3839-52. PubMed ID: 26018676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow.
    Nolta JA; Yu XJ; Bahner I; Kohn DB
    J Clin Invest; 1992 Aug; 90(2):342-8. PubMed ID: 1379609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the c.(-203)A>G variant in the glucocerebrosidase gene and its association with phenotype in Gaucher disease.
    Alfonso P; Pampín S; García-Rodríguez B; Tejedor T; Domínguez C; Rodríguez-Rey JC; Giraldo P; Pocoví M
    Clin Chim Acta; 2011 Jan; 412(3-4):365-9. PubMed ID: 21087600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells.
    Iio A; Takagi T; Miki K; Naoe T; Nakayama A; Akao Y
    Biochim Biophys Acta; 2013 Oct; 1829(10):1102-10. PubMed ID: 23932921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VP22 enhances the expression of glucocerebrosidase in human Gaucher II fibroblast cells mediated by lentiviral vectors.
    Jin GS; Zhu GD; Zhao ZG; Liu FS
    Clin Exp Med; 2012 Sep; 12(3):135-43. PubMed ID: 21874584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gaucher disease and parkinsonism: a phenotypic and genotypic characterization.
    Tayebi N; Callahan M; Madike V; Stubblefield BK; Orvisky E; Krasnewich D; Fillano JJ; Sidransky E
    Mol Genet Metab; 2001 Aug; 73(4):313-21. PubMed ID: 11509013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gaucher disease paradigm: from ERAD to comorbidity.
    Bendikov-Bar I; Horowitz M
    Hum Mutat; 2012 Oct; 33(10):1398-407. PubMed ID: 22623374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complete restoration of glucocerebrosidase deficiency in Gaucher fibroblasts using a bicistronic MDR retrovirus and a new selection strategy.
    Aran JM; Licht T; Gottesman MM; Pastan I
    Hum Gene Ther; 1996 Nov; 7(17):2165-75. PubMed ID: 8934230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High risk screening for Gaucher disease in patients with splenomegaly and/or thrombocytopenia in China: 55 cases identified.
    Huang Y; Jia X; Tang C; Liu S; Sheng H; Zhao X; Zeng C; Liu L
    Clin Chim Acta; 2020 Jul; 506():22-27. PubMed ID: 32165122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lysosome sorting of β-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor.
    Zhao Y; Ren J; Padilla-Parra S; Fry EE; Stuart DI
    Nat Commun; 2014 Jul; 5():4321. PubMed ID: 25027712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity.
    Diaz-Font A; Cormand B; Santamaria R; Vilageliu L; Grinberg D; Chabás A
    Hum Genet; 2005 Jul; 117(2-3):275-7. PubMed ID: 15856305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease.
    Jian J; Tian QY; Hettinghouse A; Zhao S; Liu H; Wei J; Grunig G; Zhang W; Setchell KDR; Sun Y; Overkleeft HS; Chan GL; Liu CJ
    EBioMedicine; 2016 Nov; 13():212-224. PubMed ID: 27789271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).
    Hruska KS; LaMarca ME; Scott CR; Sidransky E
    Hum Mutat; 2008 May; 29(5):567-83. PubMed ID: 18338393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bicyclic derivatives of L-idonojirimycin as pharmacological chaperones for neuronopathic forms of Gaucher disease.
    Alfonso P; Andreu V; Pino-Angeles A; Moya-García AA; García-Moreno MI; Rodríguez-Rey JC; Sánchez-Jiménez F; Pocoví M; Ortiz Mellet C; García Fernández JM; Giraldo P
    Chembiochem; 2013 May; 14(8):943-9. PubMed ID: 23606264
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gaucher disease: molecular screening of the glucocerebrosidase 1601G and 1601A alleles in Victoria, British Columbia, Canada.
    Choy FY; Linsey J; MacLeod PD
    J Med Genet; 1997 Jan; 34(1):83-5. PubMed ID: 9032656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease.
    Jung O; Patnaik S; Marugan J; Sidransky E; Westbroek W
    Expert Rev Proteomics; 2016 May; 13(5):471-9. PubMed ID: 27098312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease.
    Atrian S; López-Viñas E; Gómez-Puertas P; Chabás A; Vilageliu L; Grinberg D
    Proteins; 2008 Feb; 70(3):882-91. PubMed ID: 17803231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The human glucocerebrosidase gene has two functional ATG initiator codons.
    Sorge JA; West C; Kuhl W; Treger L; Beutler E
    Am J Hum Genet; 1987 Dec; 41(6):1016-24. PubMed ID: 3687939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Restoration of β-GC trafficking improves the lysosome function in Gaucher disease.
    Patel S; Radhakrishnan D; Kumari D; Bhansali P; Setty SRG
    Traffic; 2023 Oct; 24(10):489-503. PubMed ID: 37491971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.